CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Purple Biotech Says Preclinical Study Supports Advancing IM1240 to First-in-Human Trial in 2027

Phase 1IM1240Positive
AI Analysis

Summary

Purple Biotech announced that preclinical study results for IM1240 support progression to a first-in-human trial planned for 2027.

Outcome Details

Preclinical study supports advancement to first-in-human trial

Importance:4/10
Sentiment:
0.60
preclinicaldrug developmentclinical trial advancement
Related Companies
$PPBT

Read the original article

Published by yahoo_finance on June 11, 2026 12:24 PM

Read Original